A pharmacist or practitioner who proposes to make any substitution must have made use of a list of biologically equivalent drugs or interchangeable biological products approved by the United States Food and Drug Administration.
NRS 639.2597
Use of list of biologically equivalent drugs or interchangeable biological products
(Added to NRS by 1979, 1349; A 1989, 1122; 1993, 635; 2017, 636)
Official source: Nevada Legislature. Reproduced from public-domain Nevada statutes; confirm against the official source for the current text. Not legal advice.